GGrantIndex
← Leaderboards

Fumito Ichinose

Massachusetts General Hospital

$9,083,343
Attributed
$10,052,622
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $937.7K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,052,622 · 7

By mechanism

R01$8,962,422 · 5
K08$653,400 · 1
R21$436,800 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Prevent

Research focus

PreventNitric OxideAttenuatedCessation Of LifeFunctional DisorderBaseBrain InjuriesBrainMouse ModelMyocardialResponseCardiacLifeSyndromeHeart ArrestCaringNeuronsCause Of DeathNovel TherapeuticsReperfusion InjuryCardiopulmonary ResuscitationAnimalsMetabolismProduction

Grant awards (29)

Role of Sedation in the Post-Cardiac Arrest Neurological Recovery$435,827
R01 · FY2025 · NS · contact PI
Role of Sedation in the Post-Cardiac Arrest Neurological Recovery$521,017
R01 · FY2024 · NS · contact PI
Role of Sedation in the Post-Cardiac Arrest Neurological Recovery$533,447
R01 · FY2023 · NS · contact PI
Role of sulfide catabolism in ischemic brain injury$349,650
R01 · FY2023 · NS · contact PI
Role of sulfide catabolism in ischemic brain injury$349,650
R01 · FY2022 · NS · contact PI
Role of sulfide catabolism in ischemic brain injury$349,650
R01 · FY2021 · NS · contact PI
Novel Antidotes for H2S Poisoning$188,900
R21 · FY2021 · NS · contact PI
Role of sulfide catabolism in ischemic brain injury$349,650
R01 · FY2020 · NS · contact PI
Novel Antidotes for H2S Poisoning$247,900
R21 · FY2020 · NS · contact PI
Role of sulfide catabolism in ischemic brain injury$349,650
R01 · FY2019 · NS · contact PI
Improving Outcomes in Cardiac Arrest/CPR with Inhaled Nitric Oxide$527,452
R01 · FY2015 · HL · contact PI
Improving Outcomes in Cardiac Arrest/CPR with Inhaled Nitric Oxide$514,975
R01 · FY2014 · HL · contact PI
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS$422,589
R01 · FY2014 · HL · contact PI
Improving Outcomes in Cardiac Arrest/CPR with Inhaled Nitric Oxide$478,009
R01 · FY2013 · HL · contact PI
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS$409,065
R01 · FY2013 · HL · contact PI
Improving Outcomes in Cardiac Arrest/CPR with Inhaled Nitric Oxide$508,774
R01 · FY2012 · HL · contact PI
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS$428,927
R01 · FY2012 · HL · contact PI
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS$433,260
R01 · FY2011 · HL · contact PI
Impact of nitric oxide synthase on myocardial dysfunction of sepsis$309,124
R01 · FY2011 · GM · contact PI
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS$433,260
R01 · FY2010 · HL · contact PI
Impact of nitric oxide synthase on myocardial dysfunction of sepsis$312,246
R01 · FY2010 · GM · contact PI
Impact of nitric oxide synthase on myocardial dysfunction of sepsis$315,400
R01 · FY2009 · GM · contact PI
Impact of nitric oxide synthase on myocardial dysfunction of sepsis$315,400
R01 · FY2008 · GM · contact PI
Nitric Oxide/cGMP/Endotoxin-Induced Myocardial Dysfunct$130,680
K08 · FY2008 · HL · contact PI
Impact of nitric oxide synthase on myocardial dysfunction of sepsis$315,400
R01 · FY2007 · GM · contact PI
Nitric Oxide/cGMP/Endotoxin-Induced Myocardial Dysfunct$130,680
K08 · FY2007 · HL · contact PI
Nitric Oxide/cGMP/Endotoxin-Induced Myocardial Dysfunct$130,680
K08 · FY2006 · HL · contact PI
Nitric Oxide/cGMP/Endotoxin-Induced Myocardial Dysfunct$130,680
K08 · FY2005 · HL
Nitric Oxide/cGMP/Endotoxin-Induced Myocardial Dysfunct$130,680
K08 · FY2004 · HL